130 related articles for article (PubMed ID: 24351623)
1. A case of disseminated nontuberculous mycobacteriosis and cerebellar toxoplasmosis with autoantibody to interferon-γ.
Yamaguchi E; Tanaka H; Fukuoka T; Ohbayashi Y; Sato M; Yokoi T
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Dec; 30(4):312-6. PubMed ID: 24351623
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].
Picque JB; Blot M; Binois R; Jeudy G; Simonet AL; Cagnon J; Mahy S; Duong M; Buisson M; Chavanet P; Piroth L
Rev Med Interne; 2012 Feb; 33(2):103-6. PubMed ID: 22236500
[TBL] [Abstract][Full Text] [Related]
3. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
[TBL] [Abstract][Full Text] [Related]
4. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
[TBL] [Abstract][Full Text] [Related]
5. Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.
Hanitsch LG; Löbel M; Müller-Redetzky H; Schürmann M; Suttorp N; Unterwalder N; Mönnich U; Meisel C; Wittke K; Volk HD; Scheibenbogen C; Kölsch U
J Clin Immunol; 2015 May; 35(4):361-5. PubMed ID: 25875701
[TBL] [Abstract][Full Text] [Related]
6. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon.
Tang BS; Chan JF; Chen M; Tsang OT; Mok MY; Lai RW; Lee R; Que TL; Tse H; Li IW; To KK; Cheng VC; Chan EY; Zheng B; Yuen KY
Clin Vaccine Immunol; 2010 Jul; 17(7):1132-8. PubMed ID: 20445006
[TBL] [Abstract][Full Text] [Related]
7. [DISSEMINATED NONTUBERCULOUS MYCOBACTERIOSIS THAT IS POSITIVE FOR NEUTRALIZING ANTI-INTERFERON-GAMMA AUTOANTIBODIES: A NEW DISEASE CONCEPT BASED ON HOST FACTORS].
Sakagami T
Kekkaku; 2015 Jun; 90(6):561-4. PubMed ID: 26489159
[TBL] [Abstract][Full Text] [Related]
8. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.
Czaja CA; Merkel PA; Chan ED; Lenz LL; Wolf ML; Alam R; Frankel SK; Fischer A; Gogate S; Perez-Velez CM; Knight V
Clin Infect Dis; 2014 Mar; 58(6):e115-8. PubMed ID: 24336756
[TBL] [Abstract][Full Text] [Related]
9. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
[TBL] [Abstract][Full Text] [Related]
10. Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome: A case report.
Tanigaki T; Kimizuka Y; Maki Y; Sato C; Yoshimatsu S; Ogata H; Nomura S; Nishimura M; Serizawa Y; Ito K; Igarashi S; Kurata Y; Ohno T; Miyata J; Fujikura Y; Sato K; Ogata S; Kawana A
J Infect Chemother; 2022 Nov; 28(11):1562-1566. PubMed ID: 35931413
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
[TBL] [Abstract][Full Text] [Related]
12. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
[TBL] [Abstract][Full Text] [Related]
13. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
Tanimizu M; Mizuno K; Hashimoto M
Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
[TBL] [Abstract][Full Text] [Related]
14. Anti-interferon-gamma autoantibody related disseminated nontuberculous mycobacteriosis with pathological features of immunoglobulin G4-related disease.
Nagamura N; Imada T
Immunol Med; 2022 Mar; 45(1):48-53. PubMed ID: 34033731
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
Harada M; Furuhashi K; Karayama M; Suzuki Y; Hozumi H; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
J Infect Chemother; 2021 Feb; 27(2):373-378. PubMed ID: 33071037
[TBL] [Abstract][Full Text] [Related]
16. Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.
Otome O; O'Reilly M; Lim L
Intern Med J; 2015 Oct; 45(10):1073-6. PubMed ID: 26429217
[TBL] [Abstract][Full Text] [Related]
17. Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex.
Koya T; Tsubata C; Kagamu H; Koyama K; Hayashi M; Kuwabara K; Itoh T; Tanabe Y; Takada T; Gejyo F
J Infect Chemother; 2009 Apr; 15(2):118-22. PubMed ID: 19396523
[TBL] [Abstract][Full Text] [Related]
18. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
19. Acute generalized exanthematous pustulosis associated with anti-interferon-γ neutralizing autoantibody-positive disseminated nontuberculous mycobacterial infection.
Ogawa Y; Hasebe R; Ohnuma T; Sano S; Mitsui H; Shimada S; Ishihara H; Sakagami T; Kawamura T
Eur J Dermatol; 2019 Jun; 29(3):339-341. PubMed ID: 31251217
[No Abstract] [Full Text] [Related]
20. Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies.
Ochoa S; Ding L; Kreuzburg S; Treat J; Holland SM; Zerbe CS
Clin Infect Dis; 2021 Jun; 72(12):2206-2208. PubMed ID: 32745179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
